Voor zorgverleners

Assessing fatigue in ITP patients

For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.^1-4

FLUNITY-HD Study Demonstrated the Superior Protection Beyond Flu of High-Dose Flu Vaccine vs Standard-Dose Flu Vaccine*

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.¹

Why choose PRALUENT®?

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

A Beta way - Type 1 diabetes

Influenza can wreak havoc across major organ systems

An unpredictable virus with a devastating impact on patients’ lives^1-3,5

EVEREST study highlights

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.

Understanding Disease Modification in Atopic Dermatitis

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.¹ The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.^2,3